Abstract | OBJECTIVES: METHODS: Electronic databases were searched up to 18 August 2021. A random-effects model was applied to pool data from included studies to calculate the standardized mean differences (SMDs) for the continuous variables and relative risks (RRs) for the dichotomous variable. RESULTS: CONCLUSIONS:
|
Authors | Soheila Rezaei, Ali Taheri, Saeed Taheri, Sara Kasirzadeh, Behzad Fatemi, Mende M Sorato |
Journal | Expert review of clinical pharmacology
(Expert Rev Clin Pharmacol)
Vol. 15
Issue 6
Pg. 767-777
(Jun 2022)
ISSN: 1751-2441 [Electronic] England |
PMID | 35579011
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Insulin
- Insulin, Long-Acting
- Insulin Glargine
- Insulin Detemir
|
Topics |
- Adult
- Blood Glucose
- Diabetes Mellitus, Type 1
(drug therapy)
- Diabetes Mellitus, Type 2
(drug therapy)
- Glycated Hemoglobin
- Humans
- Hypoglycemia
(chemically induced)
- Hypoglycemic Agents
(adverse effects)
- Insulin
- Insulin Detemir
(adverse effects)
- Insulin Glargine
(adverse effects)
- Insulin, Long-Acting
(adverse effects)
- Weight Gain
|